The Next Antibiotic Revolution: Viruses to the Rescue
Dec 09, 2024
Above: Talia Backman – Ph.D. student, School of Biological Sciences, shares a micrograph of tailocins.
From multicellular organisms, like us humans, to single-cell bacteria, living things are subject to attack by viruses. Plants, animals and even bacteria have evolved strategies to combat pathogens, including viruses that can threaten health and life.
Talia Backman, a University of Utah doctoral candidate wrapping up her final year in the School of Biological Sciences, found her project and niche in studying bacteria and the viruses that infect them.
She studies how bacteria create and use weapons, called “tailocins,” by repurposing genes from viruses.
“I’m especially interested in how bacteria have taken this a step further,” Backman said, “using remnants of past viral infections as a novel defense mechanism.”
“Phage” is the word that refers to the viruses that infect bacterial cells. While phages do not attack human cells, a lot can be learned from the strategies used by bacteria to survive a viral infection. Working with Talia Karasov, the principal investigator and assistant professor of biology (yes, they share the same first name), Backman recently helped make an unexpected discovery.
Repurposing viruses
“The bacterial strains (Pseudomonas) that I am studying are essentially repurposing the viruses that infect them,” Backman said, “retaining features from the infectious particles that ultimately help them to kill or co-exist with other strains of bacteria. These repurposed phage parts are called ‘tailocins.’ Understanding the role tailocins may be playing in shaping the prevalence, survival, and evolutionary success of certain bacterial strains is not well understood and is a major focus of the research in the Karasov lab.
Research on bacteria, and their unique viral pathogens, might just offer a novel solution to the antibiotic crisis. Beyond revealing how microbial communities combat infection, compete and evolve is the adjacent opportunity and potential to discover a new class of antibiotics.
Read the full article in @School of Biological Sciences.